Agenda

Moderator(s):
Dr. Patricia Coyle
Dr. Michael Okun

Presenter(s):
Aisha Elfasi
Elsa Rodriguez
Edwin Tomy 
Jason Morency

4:30 PM ET | Conference Welcome
Michael S. Okun, MD

4:34 PM ET Session I Introduction
Patricia K. Coyle, MD

4:40 PM ET | Bringing the McDonald Criteria to Life: Diagnosing MS in the Clinic
Clyde E. Markowitz, MD

5:00 PM ET | Starting Therapy in MS: Balancing Efficacy and Safety
Mark S. Freedman, MD

5:20 PM ET | Progress in Progressive MS: Where Do We Stand?
Patricia K. Coyle, MD

5:40 PM ET | Comprehensive Care in MS: Symptoms and Treatment
Stephen Krieger, MD

5:56 PM ET | Live Q&A
Moderator: Patricia K. Coyle, MD
Mark S. Freedman, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION I
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours in the area of pharmacology. 

This activity was planned by and for the healthcare team, and learners will receive 1.5  Interprofessional Continuing Education (IPCE) credit for learning and change. 

6:16 PM ET | Session II Introductions
Mark B. Bromberg, MD, PhD

6:21 PM ET | Name That Neuromuscular Condition: Clinical Pearls in Differentiation of ALS, MMN, CIDP, and GBS
Mark B. Bromberg, MD, PhD

6:38 PM ET | Treatment Considerations in Peripheral Neuropathies: MMN, CIDP, and GBS
Karissa L. Gable, MD

6:57 PM ET | Updates on the Pathophysiology of and Therapeutic Developments in ALS
Angela Genge, MD

7:27 PM ET | Updates in Myasthenia Gravis: Diagnosis, Treatment, and Future Options
Tuan H. Vu, MD

7:57 PM ET | Live Q&A
Moderator: Mark B. Bromberg, MD, PhD
Karissa L. Gable, MD
Angela Genge, MD
Tuan H. Vu, MD

Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Supported by an independent educational grant from ACADIA Pharmaceuticals Inc.

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION II
For Physicians
Medscape, LLC designates this live activity for a maximum of 2.0  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 2.00 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.75 contact hours in the area of pharmacology. 

8:20 PM ET | Session III Introductions
Greg W. Albers, MD

8:26 PM ET | Current and Emerging Approaches to Thrombolytic Therapeutics for Stroke
Greg W. Albers, MD

8:41 PM ET | Best Practices in the Use of Endovascular Therapies in Stroke Care
Jeffrey L. Saver, MD

9:02 PM ET | Merging Clinical Data and Clinical Practice in Timing of Stroke Care
Eva A. Mistry, MBBS

9:24 PM ET | Live Q&A
Moderator: Greg W. Albers, MD
Jeffrey L. Saver, MD
Eva A. Mistry, MBBS

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION III
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours in the area of pharmacology. 

4:25 PM ET | Session IV Introduction
Sheryl Haut, MD

4:31 PM ET | Improving the Diagnosis of Epilepsy: Strategies for Interpreting Routine EEG Results
Selim R. Benbadis, MD

4:51 PM ET | Case Conversations in Selecting an Initial Epilepsy Therapy
Steve S. Chung, MD

5:11 PM ET | When and How to Change Epilepsy Therapies
Sheryl Haut, MD

5:31 PM ET | Drug Resistant Epilepsy: When to Consider Surgery and Devices
Michael R. Sperling, MD

5:51 PM ET | Pediatric Onset Epileptic Encephalopathies: Perspectives for Adult Care
Susan E. Duberstein, MD

6:11 PM ET | Live Q&A 
Moderator: Sheryl Haut, MD
Selim R. Benbadis, MD
Steve S. Chung, MD
Susan E. Duberstein, MD
Michael R. Sperling, MD

Supported by an independent educational grant from GeneDx | Sema4
Supported by an independent educational grant from Jazz Pharmaceuticals

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION IV
For Physicians
Medscape, LLC designates this live activity for a maximum of 2.00  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 2.00 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours in the area of pharmacology. 

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change. 

6:30 PM ET | Caring and Coping: A Former First Family's Experience With Vascular Parkinsonism
Jenna Bush Hager
Moderator: Michael S. Okun, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Keynote: 
For Physicians
Medscape, LLC designates this live activity for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 hours in the area of pharmacology. 

7:00 PM ET | Session V Introduction
Michael S. Okun, MD

7:06 PM ET | Pharmacotherapeutic Recommendations Across the Disease Course in Parkinson Disease
Daniel O. Claassen, MD

7:26 PM ET | Spotlight On: On-Demand Therapies for the Management of Parkinson Disease
Daniel E. Kremens, MD, JD, FAAN

7:46 PM ET | Spotlight On: Surgery and Devices for the Management of Parkinson Disease
Michael S. Okun, MD

8:06 PM ET | Live Q&A 
Moderator: Michael S. Okun, MD
Daniel O. Claassen, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION V
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours in the area of pharmacology. 

8:20 PM ET | Session VI Introduction
Ronald C. Peterson, PhD, MD

8:26 PM ET | How Low Can We Go?: Striving for Early Diagnosis of Alzheimer's Disease
Gregory A. Jicha, MD, PhD

8:46 PM ET | The Promise of Disease-Modifying Therapies in Alzheimer's Disease: What, When, and Who
James E. Galvin, MD, MPH

9:16 PM ET | Live Q&A 
Moderator: Ronald C. Peterson, PhD, MD
James E. Galvin, MD, MPH
Gregory A. Jicha, MD, PhD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Session VI
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.00 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours in the area of pharmacology. 

4:30 PM ET | Session VII Introduction
Teshamae Monteith, MD, FAHS, FAAN

4:36 PM ET | What’s the Deal With CGRP-Targeted Therapeutics in Migraine: Acute and Preventive Therapeutics
Teshamae Monteith, MD, FAHS, FAAN

5:06 PM ET | One Size Doesn’t Fit All for the Acute Treatment of Migraine: Beyond Oral Options
Teshamae Monteith, MD, FAHS, FAAN

5:16 PM ET | Is There a Role for Device-Based Therapies in Migraine Care?
Cristina Tassorelli, MD, PhD

5:36 PM ET | Live Q&A Discussion
Moderator: Teshamae Monteith, MD, FAHS, FAAN
Patricia Pozo-Rosich, MD, PhD
Cristina Tassorelli, MD, PhD

Supported by an independent educational grant from Biohaven Pharmaceuticals

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Session VII
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.00 contact hours in the area of pharmacology will be posted on the conference platform. 

6:01 PM ET | Session VIII Introduction 
Moderator: Claudia A. Chiriboga, MD, MPH, FAAN
Moderator: Perry B. Shieh, MD, PhD

6:04 PM ET | Genetics, Epidemiology, and Gene Testing for Limb Girdle Muscular Dystrophy
John F. Brandsema, MD

6:20 PM ET | Current and Emerging Approaches to Treatment of Limb Girdle Muscular Dystrophy: Is a Disease-Modifying Therapy on the Horizon?
John F. Brandsema, MD

6:38 PM ET | Strategies to Expedite Diagnosis in Duchenne Muscular Dystrophy: From Symptoms to Gene Testing
Diana P. Castro, MD

6:58 PM ET | Current and Emerging Therapies in Duchenne Muscular Dystrophy
Emma Ciafaloni, MD

Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Supported by an independent educational grant from ACADIA Pharmaceuticals Inc.
Supported by an independent educational grant from Scholar Rock Inc.

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Session VIII
For Physicians
Medscape, LLC designates this live activity for a maximum of 2.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours in the area of pharmacology. 

7:00 PM ET | Session V Introduction
Michael S. Okun, MD

7:06 PM ET | Pharmacotherapeutic Recommendations Across the Disease Course in Parkinson Disease
Daniel O. Claassen, MD

7:26 PM ET | Spotlight On: On-Demand Therapies for the Management of Parkinson Disease
Daniel E. Kremens, MD, JD, FAAN

7:46 PM ET | Spotlight On: Surgery and Devices for the Management of Parkinson Disease
Michael S. Okun, MD

8:06 PM ET | Live Q&A 
Moderator: Michael S. Okun, MD
Daniel O. Claassen, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION V
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours in the area of pharmacology. 

8:20 PM ET | Session III Introductions
Greg W. Albers, MD

8:26 PM ET | Current and Emerging Approaches to Thrombolytic Therapeutics for Stroke
Greg W. Albers, MD

8:41 PM ET | Best Practices in the Use of Endovascular Therapies in Stroke Care
Jeffrey L. Saver, MD

9:02 PM ET | Merging Clinical Data and Clinical Practice in Timing of Stroke Care
Eva A. Mistry, MBBS

9:24 PM ET | Live Q&A
Moderator: Greg W. Albers, MD
Jeffrey L. Saver, MD
Eva A. Mistry, MBBS

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION III
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours in the area of pharmacology. 

4:30 PM ET | Conference Welcome
Michael S. Okun, MD

4:34 PM ET Session I Introduction
Patricia K. Coyle, MD

4:40 PM ET | Bringing the McDonald Criteria to Life: Diagnosing MS in the Clinic
Clyde E. Markowitz, MD

5:00 PM ET | Starting Therapy in MS: Balancing Efficacy and Safety
Mark S. Freedman, MD

5:20 PM ET | Progress in Progressive MS: Where Do We Stand?
Patricia K. Coyle, MD

5:40 PM ET | Comprehensive Care in MS: Symptoms and Treatment
Stephen Krieger, MD

5:56 PM ET | Live Q&A
Moderator: Patricia K. Coyle, MD
Mark S. Freedman, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

SESSION I
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours in the area of pharmacology. 

This activity was planned by and for the healthcare team, and learners will receive 1.5  Interprofessional Continuing Education (IPCE) credit for learning and change. 

6:30 PM ET | Caring and Coping: A Former First Family's Experience With Vascular Parkinsonism
Jenna Bush Hager
Moderator: Michael S. Okun, MD

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Keynote: 
For Physicians
Medscape, LLC designates this live activity for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 hours in the area of pharmacology. 

4:30 PM ET | Session VII Introduction
Teshamae Monteith, MD, FAHS, FAAN

4:36 PM ET | What’s the Deal With CGRP-Targeted Therapeutics in Migraine: Acute and Preventive Therapeutics
Teshamae Monteith, MD, FAHS, FAAN

5:06 PM ET | One Size Doesn’t Fit All for the Acute Treatment of Migraine: Beyond Oral Options
Teshamae Monteith, MD, FAHS, FAAN

5:16 PM ET | Is There a Role for Device-Based Therapies in Migraine Care?
Cristina Tassorelli, MD, PhD

5:36 PM ET | Live Q&A Discussion
Moderator: Teshamae Monteith, MD, FAHS, FAAN
Patricia Pozo-Rosich, MD, PhD
Cristina Tassorelli, MD, PhD

Supported by an independent educational grant from Biohaven Pharmaceuticals

ACCREDITATION INFORMATION

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Session VII
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.00 contact hours in the area of pharmacology will be posted on the conference platform.